Recently, the invasive and metastatic potential of prostate cancer was correlated with the expression of a voltage-gated sodium channel in human and rat prostate cancer (PCa) cell lines. A 260-kd protein, corresponding to a voltage-gated sodium channel, was identified in PC-3 and highly metastatic Mat-LyLu PCa cell lines. This sodium channel isotype was inhibited by tetrodotoxin (TTX) and identified as a voltage dependent channel. Further investigation into the relationship between human prostate expressed Na+ channel and the invasive phenotype found that TTX reduced the invasiveness of PC-3 cells by 31% (P = 0.02). Since metastatic prostate adenocarcinoma is the second most common cause of cancer-related deaths among men in North America, a large void in effective treatment regimens still exists. We hypothesize that sodium channel modulating agents will be effective in preventing or limiting PCa growth and/or metastasis. With this in mind, we propose to evaluate novel sodium channels blockers as inhibitors of LNCaP, C4-2, PC3, PC-3M and DU145 human PCa cell lines. In this new investigator proposal, we demonstrate using thymidine uptake, crystal violet growth assays, MTT, and soft agarose assays that our lead compounds inhibit androgen dependent and independent PCa cell lines. Preliminary data from our laboratory identified two classes of novel inhibitors that have potent cellular inhibitory effects at 40 micromolar when tested over 7 days of treatment. Furthermore, these analogues were more effective at inhibiting all PCa cell lines tested to date as compared to known sodium channel blocking agents like phenytoin and lidocaine. Altogether, this work lays the framework for the evaluation of these novel compounds in vivo. We are encouraged by these preliminary results and specifically aim to: 1) synthesize novel analogs of the active leads designed with systematic changes to evaluate, 2) evaluate the electrophysiological properties of the novel analogs for sodium channel activity, 3) evaluate the novel analogs for inhibition of human prostate cancer cell line (LNCaP, C4-2, PC3, PC-3M and Du-145) growth, tumorigenic and metastatic potential using in vitro model systems and 4) evaluate the novel active analogs for inhibition of human prostate cancer growth, tumorigenic and metastatic potential using in vivo model systems.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-ET-2 (04))
Program Officer
Lees, Robert G
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Virginia
Schools of Arts and Sciences
United States
Zip Code
Miles, Fayth L; Lynch, Jill E; Sikes, Robert A (2015) Cell-based assays using calcein acetoxymethyl ester show variation in fluorescence with treatment conditions. J Biol Methods 2:
Suy, Simeng; Hansen, Todd P; Auto, Heather D et al. (2012) Expression of Voltage-Gated Sodium Channel Nav1.8 in Human Prostate Cancer is Associated with High Histological Grade. J Clin Exp Oncol 1:
Walls, Thomas H; Grindrod, Scott C; Beraud, Dawn et al. (2012) Synthesis and biological evaluation of a fluorescent analog of phenytoin as a potential inhibitor of neuropathic pain and imaging agent. Bioorg Med Chem 20:5269-76
Jansson, Keith H; Lynch, Jill E; Lepori-Bui, Nadia et al. (2012) Overexpression of the VSSC-associated CAM, ?-2, enhances LNCaP cell metastasis associated behavior. Prostate 72:1080-92
Davis, Gary C; Kong, Yali; Paige, Mikell et al. (2012) Asymmetric synthesis and evaluation of a hydroxyphenylamide voltage-gated sodium channel blocker in human prostate cancer xenografts. Bioorg Med Chem 20:2180-8
Wang, Yuesheng; Jones, Paulianda J; Batts, Timothy W et al. (2009) Ligand-based design and synthesis of novel sodium channel blockers from a combined phenytoin-lidocaine pharmacophore. Bioorg Med Chem 17:7064-72
Jones, Paulianda J; Merrick, Ellen C; Batts, Timothy W et al. (2009) Modulation of sodium channel inactivation gating by a novel lactam: implications for seizure suppression in chronic limbic epilepsy. J Pharmacol Exp Ther 328:201-12
Brown, Milton L; Eidam, Hilary A; Paige, Mikell et al. (2009) Comparative molecular field analysis and synthetic validation of a hydroxyamide-propofol binding and functional block of neuronal voltage-dependent sodium channels. Bioorg Med Chem 17:7056-63
Cooper, Carlton R; Graves, Bianca; Pruitt, Freddie et al. (2008) Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha. J Cell Biochem 104:2298-309
Lenkowski, Paul W; Batts, Timothy W; Smith, Misty D et al. (2007) A pharmacophore derived phenytoin analogue with increased affinity for slow inactivated sodium channels exhibits a desired anticonvulsant profile. Neuropharmacology 52:1044-54

Showing the most recent 10 out of 14 publications